Oramed Pharmaceuticals Inc. — Director's Dealing 2016

May 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP)
CIK: 0001176309
Period of Report: 2016-05-20

Reporting Person: Sank Leonard (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-20	Common Stock	A	3000	$8.57	Acquired	270896	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	78125	Indirect
Common Stock	138889	Indirect

Footnotes

F1: Mr. Sank disclaims beneficial ownership of these shares.

F2: These shares consist of shares of common stock owned by a company wholly owned by a trust of which Mr. Sank is a trustee. Mr. Sank disclaims beneficial ownership of these shares.